Ostin Technology Group Announces Results of Extraordinary General Meeting
November 27, 2024 16:30 ET
|
Ostin Technology Group Co., Ltd.
Nanjing, China, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Ostin Technology Group Co., Ltd. ("the Company") (Nasdaq: OST), a leading supplier of display modules and polarizers based in China, announced the...
Informations sur le nombre total de droits de vote et d'actions
November 27, 2024 16:30 ET
|
Nyxoah
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 novembre 2024, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la...
Information on the total number of voting rights and shares
November 27, 2024 16:30 ET
|
Nyxoah
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), November 27, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the...
Digital Ally, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
November 27, 2024 16:20 ET
|
Digital Ally, Inc.
Lenexa, KS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on November 25, 2024, which...
Royalty Pharma to Present at Upcoming Investor Conferences
November 27, 2024 16:15 ET
|
Royalty Pharma plc
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December: ...
Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A
November 27, 2024 16:15 ET
|
Fundamental Global Inc.
Mooresville, NC, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGF) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc., today announced that it...
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
November 27, 2024 16:15 ET
|
OneMedNet Corporation
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
November 27, 2024 16:10 ET
|
Applied Therapeutics
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced...
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
November 27, 2024 16:05 ET
|
Titan Pharmaceuticals, Inc.
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing...
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
November 27, 2024 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...